HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Complete response of monoblastic myeloid sarcoma with FIP1L1- PDGFRA rearrangement to imatinib monotherapy.

AuthorsUpendra Srinivas, Adarsh Barwad, Sushma Venkata Pubbaraju
JournalBritish journal of haematology (Br J Haematol) Vol. 165 Issue 5 Pg. 583 (Jun 2014) ISSN: 1365-2141 [Electronic] England
PMID24456122 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antineoplastic Agents
  • Benzamides
  • Oncogene Proteins, Fusion
  • Piperazines
  • Pyrimidines
  • mRNA Cleavage and Polyadenylation Factors
  • Imatinib Mesylate
  • FIP1L1-PDGFRA fusion protein, human
  • Receptor, Platelet-Derived Growth Factor alpha
Topics
  • Antineoplastic Agents (therapeutic use)
  • Benzamides (therapeutic use)
  • Gene Rearrangement
  • Humans
  • Imatinib Mesylate
  • Male
  • Oncogene Proteins, Fusion (genetics)
  • Piperazines (therapeutic use)
  • Pyrimidines (therapeutic use)
  • Receptor, Platelet-Derived Growth Factor alpha (genetics)
  • Sarcoma, Myeloid (drug therapy, genetics, pathology)
  • Treatment Outcome
  • Young Adult
  • mRNA Cleavage and Polyadenylation Factors (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: